Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Wanbury
Quarter-by-quarter operating performance
| Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 126 | 133 | 146 | 144 | 146 | 139 | 131 | 161 | 133 | 172 | 163 | 160 | 162 |
| Expenses + | 119 | 119 | 133 | 127 | 124 | 121 | 120 | 141 | 120 | 142 | 139 | 134 | 136 |
| Operating Profit | 6 | 14 | 13 | 17 | 21 | 18 | 11 | 20 | 14 | 30 | 24 | 26 | 27 |
| OPM % | 5% | 11% | 9% | 12% | 15% | 13% | 8% | 12% | 10% | 17% | 15% | 16% | 16% |
| Other Income + | 0 | -3 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 0 | 0 | 0 |
| Interest | 7 | 8 | 6 | 8 | 8 | 7 | 8 | 10 | 10 | 9 | 8 | 7 | 7 |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 |
| Profit before tax | -3 | 1 | 5 | 7 | 10 | 8 | 1 | 8 | 1 | 19 | 14 | 15 | 16 |
| Tax % | 8% | -11% | 6% | -2% | -0% | 3% | 0% | 2% | 5% | -6% | 1% | -0% | 1% |
| Net Profit + | -3 | 1 | 5 | 7 | 10 | 8 | 1 | 8 | 1 | 20 | 13 | 15 | 16 |
| EPS in Rs | -1.00 | 0.31 | 1.43 | 2.25 | 3.14 | 2.47 | 0.32 | 2.45 | 0.37 | 6.18 | 4.10 | 4.35 | 4.52 |
Financials of Wanbury
Annual income statement trend
| Sep 2014 18m | Mar 2015 6m | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 661 | 250 | 420 | 432 | 370 | 391 | 367 | 392 | 511 | 500 | 578 | 600 | 658 |
| Expenses + | 620 | 228 | 387 | 414 | 438 | 375 | 344 | 374 | 475 | 476 | 506 | 523 | 551 |
| Operating Profit | 41 | 21 | 34 | 19 | -68 | 16 | 23 | 18 | 36 | 23 | 72 | 77 | 107 |
| OPM % | 6% | 9% | 8% | 4% | -18% | 4% | 6% | 5% | 7% | 5% | 12% | 13% | 16% |
| Other Income + | -237 | 6 | 0 | 90 | 76 | 9 | 84 | 2 | 77 | 0 | 1 | 3 | 3 |
| Interest | 48 | 19 | 32 | 36 | 31 | 40 | 33 | 23 | 21 | 21 | 29 | 37 | 31 |
| Depreciation | 23 | 5 | 9 | 10 | 10 | 10 | 10 | 10 | 11 | 12 | 13 | 13 | 14 |
| Profit before tax | -267 | 4 | -7 | 62 | -32 | -25 | 65 | -12 | 81 | -10 | 31 | 30 | 64 |
| Tax % | 1% | 28% | 0% | 1% | -1% | -1% | 0% | 2% | -0% | 1% | 1% | -3% | |
| Net Profit + | -270 | 3 | -7 | 62 | -32 | -25 | 64 | -13 | 81 | -10 | 30 | 31 | 65 |
| EPS in Rs | -135.21 | 1.61 | -3.52 | 26.71 | -13.49 | -10.48 | 25.79 | -5.04 | 24.94 | -3.18 | 9.28 | 9.32 | 19.15 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Financials of Wanbury
Capital structure and asset base
| Sep 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 20 | 20 | 20 | 23 | 24 | 24 | 25 | 25 | 33 | 33 | 33 | 33 | 35 |
| Reserves | -186 | -188 | -183 | -151 | -183 | -207 | -143 | -156 | -30 | -40 | -5 | 26 | 72 |
| Borrowings + | 389 | 381 | 373 | 273 | 224 | 233 | 164 | 166 | 74 | 68 | 116 | 179 | 196 |
| Other Liabilities + | 182 | 182 | 176 | 265 | 207 | 235 | 231 | 253 | 275 | 241 | 199 | 176 | 153 |
| Total Liabilities | 404 | 394 | 386 | 411 | 271 | 285 | 277 | 288 | 351 | 302 | 343 | 414 | 457 |
| Fixed Assets + | 174 | 164 | 180 | 186 | 178 | 172 | 164 | 167 | 167 | 167 | 167 | 201 | 199 |
| CWIP | 13 | 19 | 14 | 10 | 10 | 9 | 14 | 11 | 2 | 2 | 3 | 5 | 13 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets + | 218 | 212 | 192 | 215 | 83 | 103 | 99 | 109 | 182 | 133 | 173 | 208 | 244 |
| Total Assets | 404 | 394 | 386 | 411 | 271 | 285 | 277 | 288 | 351 | 302 | 343 | 414 | 457 |
Financials of Wanbury
Operating, investing and financing cash movement
| Sep 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 74 | 40 | 43 | 43 | 32 | 30 | 44 | 17 | 41 | 20 | 5 | 26 |
| Cash from Investing Activity + | -7 | -5 | -20 | -13 | -1 | -3 | 64 | 8 | 1 | -9 | -17 | -51 |
| Cash from Financing Activity + | -75 | -30 | -28 | -27 | -33 | -27 | -108 | -17 | -29 | -32 | 14 | 26 |
| Net Cash Flow | -9 | 5 | -5 | 3 | -2 | -0 | -0 | 7 | 13 | -21 | 2 | 1 |
| Free Cash Flow | 62 | 35 | 22 | 29 | 30 | 25 | 36 | 12 | 42 | 7 | -9 | -23 |
| CFO/OP | 180% | 187% | 129% | 234% | -49% | 188% | 188% | 97% | 113% | 86% | 7% | 35% |
Financials of Wanbury
Working capital efficiency and return ratios
| Sep 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 57 | 144 | 65 | 71 | 29 | 41 | 50 | 32 | 45 | 50 | 56 | 70 |
| Inventory Days | 42 | 103 | 69 | 63 | 27 | 36 | 25 | 41 | 60 | 26 | 43 | 47 |
| Days Payable | 112 | 300 | 171 | 259 | 173 | 208 | 252 | 220 | 218 | 178 | 196 | 172 |
| Cash Conversion Cycle | -13 | -54 | -37 | -124 | -117 | -131 | -176 | -147 | -112 | -101 | -96 | -55 |
| Working Capital Days | -44 | -139 | -123 | -164 | -251 | -230 | -211 | -227 | -134 | -129 | -37 | 4 |
| ROCE % | 6% | 12% | 55% | -1% | 26% | 31% | 23% | 46% | 17% | 58% | 34% |
Focused growth in six core therapy areas: cardiology, pain management, women's health, CNS, transplant, and ophthalmology, which contribute 40-50% of…
Expansion plans supported by capex of INR 200-250 crores annually, with 60% towards expansion/new products and 40% towards efficiency improvements. Key concall…
The company is confident of achieving 20%+ volume growth backed by steady ramp-up in Jammu and existing facilities. Key concall takeaways from Innova Captab…
Chronic respiratory segment in India showing over 25% growth; oncology and cardiovascular segments also strong. Key concall takeaways from Glenmark…